The results showed that the proliferation and migration of pancreatic cancer cells were significantly inhibited after adding the LIF inhibitor, and the inhibition was significant as the inhibitor concentration increased (Figure 7H–K). The gene discussed is LIF; the disease is familial pancreatic carcinoma.